Navigation Links
Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests
Date:12/11/2008

squamous NSCLC patients. The importance of accurately identifying squamous cell lung cancer patients has been receiving growing attention from the medical community as data has shown that squamous patients respond differently to targeted therapies, approved or in advanced development, than non squamous patients. The difference in response can range from potential fatal bleeding to poor response."

"Given the varying outcomes of targeted therapies for NSCLC, we view every NSCLC patient, who is a candidate for targeted therapy, as a potential end-user for this test," said Ronen Tamir, Chief Commercialization Officer at Rosetta Genomics. "This groundbreaking test, with its high sensitivity and specificity, will enable doctor and patient to adjust expectations, and answer a real unmet medical need."

miRview(TM) squamous classifies non-small cell lung carcinoma samples into two histological groups: cancers of squamous histology, and non-squamous cancers. The test leverages proprietary microRNA technology developed by Rosetta Genomics, and measures the expression level of a microRNA squamous biomarker to differentiate patients that have squamous cell carcinoma of the lung from patients that have non-squamous non-small cell lung cancer.

Patients with squamous cell carcinoma of the lung have shown varying response patterns to targeted therapies, whether currently available or under development, ranging from a high incidence of severe or fatal hemoptysis (internal bleeding in the lungs) to overall poor response.

Current methods for differentiating squamous from non squamous non-small cell lung cancer lack standardization, are difficult to reproduce, and have low accuracy. Studies that reviewed the accuracy and reproducibility of histopathological classification of lung cancer found that 30%~40% of samples had been misclassified.

Rosetta Genomics will host a conference call with a simul
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
2. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
5. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
6. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
7. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
8. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
9. Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
10. MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
11. Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics miRview(TM) Squamous Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
(Date:5/23/2013)... ARBOR, Mich. , May 23, 2013  Every day, ... flow of air to his lungs. April and ... the dire predictions weren,t true. "Quite a few ... the hospital alive," says April Gionfriddo , ... were desperate. Anything that would work, we would take it ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... LONDON, Feb. 9, 2012   Smith & Nephew ... medical technology business, is introducing the clinically proven POLARCUP™ ... US at this year,s American Academy of Orthopaedic Surgeons ... specifically designed to address the challenges of treating patients ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... its common stock pursuant to an effective shelf registration statement ... sole book-running manager of the offering, and Halozyme intends to ... to an additional 1,020,000 shares of common stock. All of ...
Cached Medicine Technology:POLARCUP™ Dual Mobility Hip System From Smith & Nephew Now Available in US 2POLARCUP™ Dual Mobility Hip System From Smith & Nephew Now Available in US 3Halozyme Announces Proposed Public Offering of Common Stock 2Halozyme Announces Proposed Public Offering of Common Stock 3
(Date:5/24/2013)... 23 May 2013, Paris, France: A new investigational device ... use with the Sapien XT Transcatheter Heart Valve was ... first-in-human feasibility study of its use in high-risk aortic ... system acts as an anchor to help stabilise the ... native leaflets in the heart are captured between the ...
(Date:5/24/2013)... The producers of Health Briefs TV ... North Carolina. It is one of the largest cities in ... city is populated with more than a million people who ... both North and South Carolina. Viewers who are interested in ... into WAXN-TV 64 Eyewitness News during the month of May. ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... nutrition school, is happy to announce that it has donated ... that supports the women held captive in Cleveland, Ohio. , ... Gina de Jesus, Michelle Knight, and Amanda Berry and her ... captive for a decade, we were shocked and horrified,” said ...
(Date:5/24/2013)... missed more than half of recommended well-child visits had ... children who attended most of their visits, according to ... of Managed Care . The study included more than ... Children with chronic conditions like asthma and heart disease ... missed visits, according to the study. In fact, ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The Icahn ... Dynamics International (CDI) exclusive license rights to commercially ... regenerative medicine applications. These cells are capable of further ... including cardiomyocytes, endothelial cells, and vascular smooth muscle cells, ... for damaged heart tissue. , The original agreement announced ...
Breaking Medicine News(10 mins):Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4
... in gulls is the same as in humans, and a ... of Mediterranean gulls in southern France have some form of ... the journal PLoS One . Bacteria that develop ... and are having a major impact on our ability to ...
... people each year, with costs reaching into the billions ... Care Certified professionals are becoming a growing clinical specialty. ... National Alliance of Wound Care (NAWC(R)), a multi-disciplinary professional ... 7000 health care professionals as WCC(R)s (Wound Care Certified). ...
... , Zone Diet makes it easy for men and women to ... , DANVERS, Mass., June 18 If you,ve thought twice about ... alone. A new survey from ZoneDiet.com reveals ... body looks during the summer - and nearly half (49 percent) ...
... 10 specialties and Honor Roll - , , WASHINGTON, ... second annual rankings by specialty of America,s Best Children,s Hospitals, ... in the August issue of U.S. News & World ... , The 2009 America,s Best Children,s Hospitals, the most ...
... , SAN DIEGO, June 18 , , What: At the ... Meeting in San Diego, Microsoft Corp. will showcase Microsoft, ... such as these:, ... Office System, ...
... still lack access to quality food and grocery stores , ... report Examining the Impact of Food Deserts on Public Health ... deserts," communities where fresh, quality food is hard to come by ... , A wide range of market, community and government actors used ...
Cached Medicine News:Health News:ZoneDiet.com Survey Reveals That Body Insecurity Prevents Nearly Half (49%) of Americans From Engaging in Summer Activities 2Health News:ZoneDiet.com Survey Reveals That Body Insecurity Prevents Nearly Half (49%) of Americans From Engaging in Summer Activities 3Health News:U.S. News Media Group Releases Rankings of America's Best Children's Hospitals 2Health News:U.S. News Media Group Releases Rankings of America's Best Children's Hospitals 3Health News:Microsoft to Showcase Clinical Trial Solutions From Discovery to Approvals at Drug Information Association's 2009 Annual Meeting 2Health News:Chicago Making Progress Shrinking Vast 'Food Desert' 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: